Introduction
============

Cancer is one of the major public health and healthcare system challenges worldwide that is reaching pandemic proportions.[@b1-cmar-10-1285] In 2012, 14.1 million incident cancer cases were diagnosed and 8.2 million deaths were attributed to cancer worldwide.[@b2-cmar-10-1285] Incidentally, the burden of cancer is also increasing in Saudi Arabia reaching a total of 15,807 new cases reported in the year 2014[@b3-cmar-10-1285] and potentially affecting the quality of life of patients.[@b4-cmar-10-1285]

Although the diagnostic and therapeutic advancements in cancer management were largely beneficial, they have the potential to impact the entire human body and can have a major impact on oral health.[@b5-cmar-10-1285] Previous studies found several oral complications in cancer patients, including oral mucositis (OM), dental caries, xerostomia (dryness of mouth), osteoradionecrosis, oropharyngeal candidiasis, ulcerations, difficulty in swallowing (dysphagia), neurosensory taste disturbances (dysgeusia), limited mouth opening (trismus), periodontal diseases and tooth mobility, and halitosis; these oral complications could be acute or chronic and might arise during or after cancer treatment.[@b5-cmar-10-1285]--[@b7-cmar-10-1285] Therefore, disregarding oral health in cancer patients would affect the quality of life with potential implications on morbidity and mortality.[@b5-cmar-10-1285],[@b8-cmar-10-1285] The wide range of incidence of OM (10%--100%) reported in the literature reveal varied therapeutic susceptibility among cancer patients.[@b9-cmar-10-1285]--[@b11-cmar-10-1285] Furthermore, the reduced salivary flow reported in cancer patients increases the risk of oral infections and susceptibility to dental caries, which would consequently affect the daily functions and induce problems such as difficulties in speech, chewing, and swallowing to the detriment of quality of life.[@b12-cmar-10-1285]--[@b14-cmar-10-1285]

It is noteworthy that physicians tend to prioritize life-threatening conditions and neglect oral health in cancer patients.[@b15-cmar-10-1285],[@b16-cmar-10-1285] Oral health assessment and treatment should be an integral part of cancer patient management practices to maintain good oral hygiene. Subsequent preservation of daily functions and prevention of infectious diseases would aid in achieving a better quality of life in cancer patients. To the best of our knowledge, no prior research was conducted in Saudi Arabia to evaluate the existence of oral health conditions in cancer patients and their associated factors. Our study would address this important gap in the literature by determining the burden of oral health conditions (by estimating their prevalence) in adult Saudi population and also identifying the common factors associated with oral health conditions experienced by patients attending the oncology outpatient clinics at King Abdulaziz Medical City -- Riyadh (KAMC-R), Saudi Arabia. The findings from our research could potentially aid in informing patients as well as healthcare providers (eg, interns, dentists, and oncologists) in improving the assessment and management practices of cancer patients.

Materials and methods
=====================

An observational cross-sectional study design was used to determine the prevalence and common associated factors for oral health conditions experienced by adult cancer patients aged ≥18 years visiting oncology outpatient clinics at KAMC-R between April 2017 and August 2017. KAMC-R is one of the biggest tertiary hospitals in Saudi Arabia and the Middle East with an Oncology Department, providing comprehensive cancer treatment and care to thousands of patients each year. The hospital serves the population of the National Guard and their dependents, in addition to patient referrals from all over the kingdom and the Gulf region.

The study population, specifically, included both male and female adult cancer survivors, aged ≥18 years, who had no evident cognitive impairment and agreed to enroll in the study. Both Saudis and non-Saudis were included. Patients receiving palliative care and those diagnosed with head and neck cancers were excluded from the study population. A written informed consent was obtained from all the participants. Our study received scientific and ethics approval from Institutional Review Board office at King Abdullah International Medical Research Center (KAIMRC), Riyadh (\# RC16/213/R).

Sample size and sampling strategy
---------------------------------

The sample size was estimated based on 95% confidence level and a precision of 5%. The expected prevalence used in the sample size calculations was derived from a systematic review performed in 2010,[@b7-cmar-10-1285] which reported an overall prevalence of dental diseases to be 28.1% in cancer patients undergoing therapy. Using the formula for single proportion estimation, a total sample of 311 cancer patients was recommended for this study. The study has 81% power to detect the expected effect size.

A consecutive sampling method was employed to recruit patients with different types of cancer who fulfilled aforementioned inclusion and exclusion criteria and attended oncology outpatient clinics at KAMC-R, during the study period. A total of 375 cancer patients (75%) agreed to participate in our study among 500 eligible patients who were approached for recruitment.

Self-reported questionnaire
---------------------------

A self-reported questionnaire was used to collect the information on patient's sociodemographic and lifestyle characteristics, such as age, gender, education status, income levels, marital status, family support, smoking, and physical exercise. Patients also reported whether they experienced any of the following seven oral health conditions during a period of 6 months -- bleeding gums, dental pain (toothache), mouth ulcers, bruxism (teeth grinding), xerostomia (dryness of oral cavity), problems affecting speech, and satisfactory dietary intake. In addition, information on cancer type, cancer stage, and type of treatment received, number of tumors, time elapsed since cancer diagnosis, information on comorbid chronic disease other than cancer, health insurance coverage, receipt of any form of oral health education, self-declared physical activity (yes vs no), and oral hygiene habits (frequent tooth brushing for two or more times per day and use of dental floss) was also collected. Furthermore, we assessed stress, depression, and anxiety in cancer patients using Depression Anxiety and Stress Scale.[@b17-cmar-10-1285] Face validity of our study questionnaire was established. The construct validity of our questionnaire about oral health was good as all the items of oral health contributed to a single construct with factor loadings ranging from 0.33 for xerostomia to 0.64 for mouth ulcers.

Questionnaire responses were used to construct categorical variables with meaningful categories that have sufficient sample. If patients were diagnosed with cancer within a year prior to study enrolment, they were defined as newly diagnosed patients. Patients were classified as depressed, anxious, and stressed out if they scored more than 4, 3, and 7 on their respective scales. Further details of the categories of all the variables could be found in the "Results" section.

Oral health status
------------------

The outcome of interest, oral health status, was defined based on a count variable that represented number of oral health conditions experienced by cancer patients. The overall reliability of this oral health measure was determined to be good (Cronbach's coefficient alpha=0.67).

Statistical analysis
--------------------

All statistical tests were performed with SAS software version 9.4 (SAS Institute Inc., Cary, NC, USA). Descriptive data for categorical variables were reported as frequency counts and percentages (%). The means and SD were reported for continuous variables. The prevalence of oral health status was summarized as percentage based on patients experiencing at least one of the seven oral health conditions, and 95% CIs for proportions were constructed using Clopper--Pearson exact tests. Poisson regression analyses were used to identify the factors associated with number of oral health conditions experienced by cancer patients. The unadjusted (uRR) and adjusted risk ratios (aRR) and their respective 95% CIs and two-tailed *p*-values were reported for all the variables analyzed using both univariate and multivariate Poisson regression models, respectively. Multi-collinearity was assessed using condition indices and eigenvalues. The goodness-of-fit of the Poisson regression model was assessed using Pearson chi-square test; a nonsignificant test indicates that there was no issue of overdispersion and Poisson regression is suitable for the analysis. Graphical illustrations were used to compare the expected mean number of oral health complaints by different types of cancers. Patients for whom information of the covariate in the model is unknown or missing were deleted from the analysis. A two-tailed *p*-value of ≤0.05 was considered statistically significant.

Results
=======

A total of 375 cancer patients were recruited in our study, and our analyses were based on 283 patients who had information on all the covariates in the multivariate model. The prevalence of cancer patients experiencing at least one oral health condition was 86.1% (95% CI: 82.2%--89.5%). Xerostomia (66.7%), dental pain (44%), and bleeding gums (36.8%) were the most common oral health complaints reported by cancer patients.

The mean age and SD of cancer patients were 51.8 years and 14.7 years, respectively. [Table 1](#t1-cmar-10-1285){ref-type="table"} provides the descriptive statistics as frequencies and percentages for various characteristics of study population. Briefly, majority of patients were female, married, and had either secondary or less than secondary education. About 37% of the patients belonged to extremely low economic status that earned \<5,000 Saudi riyals per month. The study sample predominantly comprised of patients suffering from colon and breast cancer, about half the subjects had single tumors. Incidentally, 65% of cancer patients were newly diagnosed patients who were diagnosed during a period of 1 year prior to enrollment into this study. An overwhelming majority of patients underwent chemotherapy followed by other treatment modalities, including immunotherapy, radiation therapy, and surgery. It is noteworthy that majority of the cancer patients were anxious, and \>40% were either depressed or stressed out.

The uRR and aRR including their 95% CIs for the association between number of oral health conditions experienced by the cancer patients and various patient characteristics were reported in [Table 2](#t2-cmar-10-1285){ref-type="table"}. The oral health complaints experienced by women are 1.4-fold higher than the complaints reported by men (aRR=1.37, 95% CI: 1.05--1.78). In addition, people who were smokers (aRR=1.29, 95% CI: 1.02--1.64) and family income \<5,000 Saudi riyals per month (aRR=1.58, 95% CI: 1.23--2.04) were associated with increased risk of experiencing adverse oral health conditions. It is noteworthy that the expected number of oral health complaints was significantly lower among breast cancer patients compared with patients suffering from colon cancer (aRR=0.72, 95% CI: 0.56--0.93); no significant differences were observed with other cancer types. The expected number of oral health conditions experienced by cancer patients was high among those suffering from anxiety (aRR=1.75, 95% CI: 1.36--2.24) and stress (aRR=1.25, 95% CI: 1.00--1.55) compared with the patients with no anxiety and stress, respectively. Multi-collinearity was not evident among variables in our model. The goodness-of-fit chi-square test for the Poisson model was nonsignificant (*p*=0.327), which indicated that Poisson regression model was appropriate for our study, and the results were not biased by overdispersion.

The expected mean number of oral health conditions among different cancer types, along with their respective 95% confidence levels, was comparatively illustrated in [Figure 1](#f1-cmar-10-1285){ref-type="fig"}. Patients diagnosed with breast cancer were expected to have experienced 1.6 (95% CI: 1.2--2.1) oral health complaints on average in comparison with the next highest number of 2.2 (95% CI: 1.8--2.6) expected conditions observed in colon cancer patients.

Discussion
==========

Our study demonstrated a significant burden (86.1%) of oral health problems experienced by cancer patients in Saudi Arabia. For the first time in the nation, we identified that female sex, low income, smoking, suffering from breast cancer, suffering from anxiety, and stress were key determinants of oral health problems in cancer patients. Our results have direct implications at improving the care of cancer patients by highlighting the need to incorporate oral health component in management of cancer patients.

The prevalence of oral health problems experienced by cancer patients in our study was considerably higher than 28.1% reported in a recent systematic review,[@b7-cmar-10-1285] indicating the severity of this problem in Saudi Arabia. Previous studies also reported wide-ranging prevalence measures for therapy-induced oral complications ranging from 10% for adjuvant chemotherapy to 91%--100% for patients treated with radiation therapy.[@b9-cmar-10-1285]--[@b11-cmar-10-1285],[@b18-cmar-10-1285] In contrast, no association was observed between various therapeutic modalities and oral health in our study possibly due to time elapsed since therapy. Therefore, future studies should address the relevance of timing of therapy on oral health problems in Saudi Arabia. As the burden of oral health conditions in cancer patients was established, it is essential to incorporate oral health management in routine cancer therapy protocols to mitigate the risk of adverse oral health on quality of life.

Female cancer patients in our study experienced poor oral health consistent with historical evidence.[@b19-cmar-10-1285] Similar trend was observed in general population, where women experienced a higher prevalence of oral lesions (58%) than men (42.3%).[@b20-cmar-10-1285] The preferred mode of dissemination of health education varied between men (eg, one-to-one method) and women (eg, one-to-one and group education);[@b21-cmar-10-1285] therefore, oncologists and other healthcare providers should tailor their oral health education programs to fulfil the needs of their patients.

In our study, low family income was among key factors associated with oral health in cancer patients, consistent with the literary evidence that linked poverty to adverse oral health in general population.[@b22-cmar-10-1285] Low-income patients encounter significant problems in accessing dental care[@b23-cmar-10-1285] and receiving adequate information on oral care from oncologists further compounding the problem.[@b24-cmar-10-1285] Therefore, care providers should emphasize the benefits of basic oral care to economically backward cancer patients and recommend or refer them to specialized dental consultation.

Our results were consistent with prior literature that identified the negative impact of smoking on oral health.[@b25-cmar-10-1285] It is interesting to note that the 1.3-fold higher risk of oral-facial pain observed in a prior study[@b25-cmar-10-1285] was consistent with the risk observed for oral conditions experienced in our population of smokers. Smokers have consistently scored poorly (24%) on the self-reported oral health status compared to nonsmokers (11%),[@b25-cmar-10-1285] emphasizing the need to rigorously pursue smoking cessation efforts in cancer patients.

It is interesting to note that the expected number of oral health problems was significantly lower in breast cancer patients compared with colon cancer patients in our study. Similarly, a recent study conducted in the USA reported 1.6 mouth sores on average among breast cancer patients.[@b26-cmar-10-1285] In another study that collectively analyzed common cancer-related and treatment-related symptoms, including xerosto-mia and pain, the percentage of moderate to severe symptoms reported by breast cancer patients was consistently lower than those reported by colorectal and lung cancer patients as noted in our study.[@b27-cmar-10-1285] Future studies could focus on identifying possible mechanisms that influenced better oral health experience in breast cancer patients.

Our study identified significant burden of anxiety among cancer patients in Saudi Arabia. We also observed a strong relationship between anxiety and adverse oral health in cancer patients; a 1.7-fold higher number of oral complaints was expected among anxious patients. Our results were consistent with prior studies that linked anxiety to oral health complaints, such as xerostomia in cancer patients[@b28-cmar-10-1285] and toothache in health sciences students.[@b29-cmar-10-1285] It was demonstrated that anxious patients tend to avoid dental care;[@b30-cmar-10-1285] therefore, cancer therapists should consider treating anxiety in patients to indirectly enhance oral health.

Stress was known to affect oral health in general[@b31-cmar-10-1285] and was specifically linked to oral ulcers,[@b32-cmar-10-1285] oral pain, gingivitis, and plaques in prior studies.[@b33-cmar-10-1285] Our study revealed a significant positive association between stress and oral health in cancer patients, thereby highlighting the need to prioritize management of stress and anxiety in Saudi cancer population.

Our study was the first in Saudi Arabia that highlighted the burden of adverse oral health and identified associated factors for oral health problems in cancer patients. In addition, this study provided baseline data that are essential to evaluate the progress of oral health in cancer patients. Our study contributed to the knowledge of risk factors of oral health in cancer patients that could have implications worldwide, and more specifically to Gulf region. The approach of collectively analyzing oral health complaints among cancer patients would benefit researchers and healthcare practitioners in better understanding the determinants of overall oral health rather than a specific condition, which in turn could lead to greater adoption of specialized oral care in routine cancer management protocols.

However, certain limitations of this study warrant caution in interpreting the results. Mainly, cross-sectional nature of this study does not allow drawing any causal inferences. However, owing to the dearth of literature in this area, our results could direct future studies by allowing hypothesis generation and providing useful information to target vulnerable populations. As self-reporting was used to collect patient information, our study was prone to recall bias; however, we expect that the effect of such a bias to be minimal owing to routine and recurrent nature of information collected. Furthermore, our questionnaire tailored to account for cultural sensitivities of Saudi cancer patients may not be suitable for wider adoption without further validation. Although our study based on a single city hospital in Saudi Arabia limits generalizability, we would expect the findings to be relevant to general population owing to cultural similarities of the Saudi populace and wide catchment area of the tertiary hospital where the sample was obtained.

Conclusion
==========

Overall, our study determined significant burden of oral health problems in cancer patients and also identified several associated factors for adverse oral health. The significant relationship between adverse oral health conditions and females, low economic groups and smokers warrant improvement of health education programs and patient counseling methods targeting these patients. Further investigation of lower risk observed uniquely in breast cancer patients is warranted to uncover underlying mechanisms that influence oral health. Healthcare practitioners should aim at incorporating detection and management of anxiety and stress in cancer patients who have profound influence on oral health.
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###### 

Descriptive statistics of study population

  Patient characteristics                           Category            Number of patients (n=375)   Percent
  ------------------------------------------------- ------------------- ---------------------------- ---------
  Age[a](#tfn1-cmar-10-1285){ref-type="table-fn"}   Mean                51.8 years                   --
  SD                                                14.7 years          --                           
  Median                                            52 years            --                           
  Gender                                            Female              216                          57.6
  Male                                              154                 41.1                         
  Missing                                           5                   1.3                          
  Marital status                                    Married             289                          77.1
  Not married                                       82                  21.9                         
  Missing                                           4                   1.1                          
  Education status                                  Secondary or less   262                          69.9
  University or higher                              95                  25.3                         
  Missing                                           18                  4.8                          
  Family income                                     \<5,000             139                          37.1
  5,000--10,000                                     122                 32.5                         
  ≥11,000                                           97                  25.9                         
  Missing                                           17                  4.5                          
  Smoking status                                    Yes                 98                           26.1
  No                                                277                 73.9                         
  Type of cancer                                    Breast cancer       125                          33.3
  Lung cancer                                       35                  9.3                          
  Leukemia                                          17                  4.5                          
  Lymph node                                        18                  4.8                          
  Colon cancer                                      170                 45.3                         
  Missing                                           10                  2.7                          
  Number of tumors                                  Single tumor        182                          48.5
  Two or more                                       165                 44.0                         
  Missing                                           28                  7.5                          
  Surgical therapy                                  Yes                 211                          56.3
  No                                                163                 43.5                         
  Missing                                           1                   0.3                          
  Chemotherapy                                      Yes                 310                          82.7
  No                                                61                  16.3                         
  Missing                                           4                   1.1                          
  Radiation therapy                                 Yes                 177                          47.2
  No                                                194                 51.7                         
  Missing                                           4                   1.1                          
  Immunotherapy                                     Yes                 226                          60.3
  No                                                143                 38.1                         
  Missing                                           6                   1.6                          
  Chronic diseases other than cancer                Yes                 145                          38.7
  No                                                223                 59.5                         
  Missing                                           7                   1.9                          
  Physical exercise                                 Yes                 115                          30.7
  No                                                260                 69.3                         
  Health insurance coverage                         Yes                 179                          47.7
  No                                                192                 51.2                         
  Missing                                           4                   1.1                          
  Received oral health information                  Yes                 148                          39.5
  No                                                223                 59.5                         
  Missing                                           4                   1.1                          
  Newly diagnosed                                   Yes                 245                          65.3
  No                                                111                 29.6                         
  Missing                                           19                  5.1                          
  Depression                                        Yes                 168                          44.8
  No                                                207                 55.2                         
  Anxiety                                           Yes                 197                          52.5
  No                                                178                 47.5                         
  Stress                                            Yes                 160                          42.7
  No                                                215                 57.3                         
  Frequent tooth brushing (≥2 times a day)          Yes                 149                          40.3
  No                                                221                 59.7                         
  Use dental floss                                  Yes                 70                           18.8
  No                                                302                 81.2                         

**Note:**

Age of cancer patients was a continuous variable. So mean, SD, and median were reported.

###### 

The uRR and aRR, including their respective 95% CIs and *p*-values for the association between number of oral health conditions experienced by the cancer patients and patient characteristics

  Characteristics                            Category            uRR                                                 95% CI                                              *p*-value                                              aRR                                                 95% CI                                              *p*-value
  ------------------------------------------ ------------------- --------------------------------------------------- --------------------------------------------------- ------------------------------------------------------ --------------------------------------------------- --------------------------------------------------- ------------------------------------------------------
  Age (years)                                --                  0.99                                                (0.99--1.00)                                        0.0640                                                 1.00                                                (0.99--1.01)                                        0.8348
  Gender                                     Female              1.35                                                (1.12--1.64)                                        0.0021[a](#tfn2-cmar-10-1285){ref-type="table-fn"}     1.37                                                (1.05--1.78)                                        0.0218[a](#tfn2-cmar-10-1285){ref-type="table-fn"}
  Male                                       1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Marital status                             Married             0.93                                                (0.74--1.18)                                        0.5669                                                 1.07                                                (0.85--1.33)                                        0.5676
  Not married                                1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Education status                           Secondary or less   1.01                                                (0.81--1.26)                                        0.9274                                                 1.00                                                (0.79--1.26)                                        0.9808
  University or higher                       1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Family income                              \<5,000             1.69                                                (1.35--2.12)                                        \<0.0001[a](#tfn2-cmar-10-1285){ref-type="table-fn"}   1.58                                                (1.23--2.04)                                        0.0004[a](#tfn2-cmar-10-1285){ref-type="table-fn"}
  5,000--10,000                              1.09                (0.85--1.41)                                        0.4873                                              1.11                                                   (0.87--1.41)                                        0.4104                                              
  ≥11,000                                    1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Smoking status                             Yes                 1.01                                                (0.82--1.24)                                        0.9394                                                 1.29                                                (1.02--1.64)                                        0.0338[a](#tfn2-cmar-10-1285){ref-type="table-fn"}
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Type of Cancer                             Breast cancer       1.14                                                (0.92--1.42)                                        0.2257                                                 0.72                                                (0.56--0.93)                                        0.0106[a](#tfn2-cmar-10-1285){ref-type="table-fn"}
  Leukemia                                   1.08                (0.68--1.73)                                        0.7432                                              1.46                                                   (0.94--2.26)                                        0.0882                                              
  Lung cancer                                1.34                (0.97--1.86)                                        0.0795                                              1.04                                                   (0.77--1.40)                                        0.8111                                              
  Lymph node                                 1.23                (0.83--1.82)                                        0.3085                                              1.28                                                   (0.88--1.85)                                        0.1994                                              
  Colon cancer                               1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Number of tumors                           Single tumor        1.00                                                (0.82--1.21)                                        0.9729                                                 1.03                                                (0.87--1.23)                                        0.7183
  Two or more                                1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Surgical therapy                           Yes                 1.17                                                (0.97--1.42)                                        0.1035                                                 1.18                                                (0.98--1.42)                                        0.0861
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Chemotherapy                               Yes                 0.97                                                (0.73--1.29)                                        0.8396                                                 1.16                                                (0.88--1.54)                                        0.2983
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Radiation therapy                          Yes                 1.11                                                (0.91-1.34)                                         0.2952                                                 1.02                                                (0.86--1.23)                                        0.7917
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Immunotherapy                              Yes                 1.03                                                (0.84--1.25)                                        0.7916                                                 0.90                                                (0.75--1.08)                                        0.2696
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Chronic diseases other than cancer         Yes                 1.03                                                (0.85--1.25)                                        0.7697                                                 0.94                                                (0.78--1.13)                                        0.5224
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Physical exercise                          Yes                 1.05                                                (0.85--1.29)                                        0.6448                                                 0.97                                                (0.79--1.18)                                        0.7445
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Health insurance coverage                  Yes                 0.74                                                (0.61--0.90)                                        0.0020[a](#tfn2-cmar-10-1285){ref-type="table-fn"}     0.90                                                (0.74--1.10)                                        0.3152
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Received oral health information           Yes                 1.07                                                (0.88--1.29)                                        0.5081                                                 1.15                                                (0.95--1.39)                                        0.1420
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Newly diagnosed                            Yes                 0.88                                                (0.72--1.08)                                        0.2343                                                 0.97                                                (0.80--1.16)                                        0.7159
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Depression                                 Yes                 1.78                                                (1.48--2.13)                                        \<0.0001[a](#tfn2-cmar-10-1285){ref-type="table-fn"}   1.09                                                (0.88--1.36)                                        0.4316
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Anxiety                                    Yes                 2.22                                                (1.84--2.66)                                        \<0.0001[a](#tfn2-cmar-10-1285){ref-type="table-fn"}   1.75                                                (1.36--2.24)                                        \<0.0001[a](#tfn2-cmar-10-1285){ref-type="table-fn"}
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Stress                                     Yes                 1.87                                                (1.57--2.24)                                        \<0.0001[a](#tfn2-cmar-10-1285){ref-type="table-fn"}   1.25                                                (1.00--1.55)                                        0.0468[a](#tfn2-cmar-10-1285){ref-type="table-fn"}
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Frequent tooth brushing (≥2 times a day)   Yes                 1.03                                                (0.85--1.25)                                        0.7816                                                 1.01                                                (0.84--1.22)                                        0.8785
  No                                         1.00                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   1.00                                                   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   
  Use dental floss                           Yes                 1.00                                                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}      1.00                                                (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}   (Ref)[b](#tfn3-cmar-10-1285){ref-type="table-fn"}
  No                                         1.00                (0.77--1.29)                                        0.9906                                              1.17                                                   (0.93--1.49)                                        0.1862                                              

**Notes:**

*p*-values reported were significant based on significance level of 0.05.

Reference category for the variable.

**Abbreviations:** uRR, unadjusted risk ratio; aRR, adjusted risk ratio.

[^1]: These authors contributed equally to this work
